Colesevelam Tablet, Film Coated
Product Images NDC 68382-619

2 FDA label images from Zydus Pharmaceuticals Usa Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Colesevelam (NDC 68382-619). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4ed4ab9b 5dd2 4132 88d0 55b28d58ba2e 01

4ed4ab9b 5dd2 4132 88d0 55b28d58ba2e 01
Chemical structure diagram of the active ingredient Colesevelam, showing its polymeric composition with repeating units and functional groups including amine and chloride ions.*
FDA Label Image

4ed4ab9b 5dd2 4132 88d0 55b28d58ba2e 02

4ed4ab9b 5dd2 4132 88d0 55b28d58ba2e 02
Label for Colesevelam Hydrochloride Tablets, 625 mg, film-coated oral tablets. The package contains 180 tablets and is labeled for prescription use only. Manufactured by Cadila Healthcare Ltd., India and distributed by Zydus Pharmaceuticals (USA) Inc. Additional information includes storage instructions and a caution to keep drugs out of reach of children.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.